Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $11
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $9 to $11.
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $9 to $11.